Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
11/2003
11/19/2003CN1456557A Method for extracting soybean isoflavone
11/19/2003CN1128143C Process for separating epoxycldohexane from light oil as by-product of oxidizing cyclohexane
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/18/2003US6649781 Recovery of minor components and refining of vegetable oils and fats
11/18/2003US6649769 For labelling a polynucleotides
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649598 4,7-dichlorofluorescein dyes as molecular probes
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/13/2003WO2003092709A1 Method for producing preparations rich in tocotrienol
11/13/2003WO2003092666A1 Calcium-containing tissue strengthening agents and use thereof
11/13/2003WO2003092613A2 Catechin multimers as therapeutic drug delivery agents
11/13/2003WO2003039461A3 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212292 Shortened synthesis of 3,3-diarylpropylamine derivatives
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212126 Bactericides, viricides; anticancer agents, antitumor agents
11/13/2003US20030212009 Isoflavone derivatives
11/13/2003US20030211184 Process for extracting polyphenolic antioxidants from purine-containing plants
11/13/2003CA2487693A1 Method for producing preparations rich in tocotrienol
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/12/2003EP1360959A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/12/2003EP1360183A1 Novel photochromic indenonaphthopyran compounds
11/12/2003EP1360182A1 4-aminobenzopyran derivatives
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003CN1455775A Method for preparing Dl-alpha-to copherol with high yield
11/12/2003CN1454896A Method of extracting oligo proanthocyanidin of grape seed
11/12/2003CN1454895A Use of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone for preparing anticancer medicine
11/12/2003CN1127495C Two-step conversion of vegetable protein isoflavone conjugates to aglucones
11/12/2003CN1127494C Neuaminic acid dervatives, their preparation and their medical use
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/12/2003CN1127337C Method of treating or preventing non-viral microbial infection
11/11/2003US6646136 Chemical intermediates for CNS drugs
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/06/2003WO2003091237A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003090770A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003016270A3 Selective estrogen receptor modulators
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002069993A8 Pharmaceutical composition made of cannabis extracts
11/06/2003WO2001094335A8 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
11/06/2003WO2001094331A8 Methods for producing amino-substituted chromanes
11/06/2003WO2001094330A8 Methods for producing amino substituted chromanes
11/06/2003US20030208079 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for proph7ylaxis of cardiovascular disorders
11/06/2003US20030208037 Novel fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
11/06/2003US20030207937 Such as ethyl-2,2-4,4-tetramethyl-chroman-6-carboxylate; for retinoid-treatable conditions
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207823 Novel diabetes imaging probes
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/05/2003EP1359136A2 Polymeric resin compounds and their preparation
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/05/2003EP0975617B1 Inhibitors of cholesterol esterase
11/05/2003CN1453274A Use and prepn process of flavone compound for treating urinary calculus and cholelithiasis
11/04/2003US6642397 Steroid sulphatase inhibitors
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642248 Antitumor, anticancer agent
11/04/2003US6641889 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer
11/04/2003US6641824 Skin treatment using a new retinoid
10/2003
10/30/2003WO2003089423A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents
10/30/2003WO2003089422A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003035636A3 Process for the preparation of 3 - isochromanone
10/30/2003US20030204114 Phenyl propenone compounds
10/30/2003US20030203962 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units
10/30/2003US20030203902 A 2-hydroxy-2-trifluoromethyl-valeroylamino benzotriazole, or benzo(1,2,5)thiadiazole, or benzo(1,2,5)oxadiazole derivatives; contraceptive agents, for treating endometriosis, gynecological disorders, male birth control
10/30/2003US20030203899 Drugs for incontinence
10/30/2003CA2482986A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith
10/29/2003EP1357118A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both
10/29/2003EP1357112A1 Novel functional peptide nucleic acid monomer and process for producing the same
10/29/2003EP1355906A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
10/29/2003EP1355898A1 Method for producing flavone derivatives
10/29/2003CN1452485A Cannabinoid drugs
10/29/2003CN1451658A Method for extracting seabucklthorn fruit all flovone in three solvent system
10/29/2003CN1125640C Prophylactic and therapeutic agent for inflammatory intestinal diseases
10/29/2003CN1125591C Plant growth regulator
10/28/2003US6639084 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
10/28/2003US6638972 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
10/28/2003US6638971 Cocoa extract compounds and methods for making and using the same
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638713 Optical molecular sensors for cytochrome P450 activity
10/28/2003US6638685 Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography
10/28/2003US6638543 Comprising an admixture of a natural inhibitor of epidermal growth factor receptor (EGFR) activation or a derivative or analog and a dermatological carrier; antipeeling agents; genistein and other isoflavones and other plant extracts
10/28/2003CA2306836C Process for the preparation of isoflavones
10/23/2003WO2003087083A1 5-alkyl-7-alkylcarbonate-isoflavone ester as isoflavone prodrug
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003086386A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003WO2002080150A3 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
10/23/2003US20030199573 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 242